Home9620 • TADAWUL
add
Balsm Alofoq Medical Company CJSC
Previous close
SAR 74.50
Year range
SAR 66.00 - SAR 85.00
Market cap
93.12M SAR
Avg Volume
152.00
P/E ratio
19.48
Dividend yield
-
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.15M | 11.50% |
Operating expense | 610.38K | -31.10% |
Net income | 1.67M | 37.92% |
Net profit margin | 32.46 | 23.70% |
Earnings per share | — | — |
EBITDA | 2.04M | 38.16% |
Effective tax rate | 6.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.24M | 396.05% |
Total assets | 33.28M | 78.37% |
Total liabilities | 4.36M | 2.18% |
Total equity | 28.92M | — |
Shares outstanding | 1.25M | — |
Price to book | 3.22 | — |
Return on assets | 13.56% | — |
Return on capital | 14.69% | — |
Cash Flow
Net change in cash
| (SAR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.67M | 37.92% |
Cash from operations | 1.85M | 11.09% |
Cash from investing | -69.40K | 97.97% |
Cash from financing | 4.68M | 3,582.25% |
Net change in cash | 6.46M | 441.07% |
Free cash flow | 1.35M | 157.33% |
About
Founded
2012
Website
Employees
81
